Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nukkleus (NUKK) EBT (2022 - 2025)

Historic EBT for Nukkleus (NUKK) over the last 4 years, with Q2 2025 value amounting to $3.2 million.

  • Nukkleus' EBT rose 35723.66% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $103.9 million, marking a year-over-year increase of 49118.93%. This contributed to the annual value of -$14.5 million for FY2024, which is 1668.01% up from last year.
  • According to the latest figures from Q2 2025, Nukkleus' EBT is $3.2 million, which was up 35723.66% from $103.1 million recorded in Q1 2025.
  • Over the past 5 years, Nukkleus' EBT peaked at $103.1 million during Q1 2025, and registered a low of -$14.3 million during Q3 2023.
  • For the 4-year period, Nukkleus' EBT averaged around $7.5 million, with its median value being -$1.2 million (2023).
  • Per our database at Business Quant, Nukkleus' EBT tumbled by 68736.41% in 2023 and then soared by 502272.07% in 2025.
  • Over the past 4 years, Nukkleus' EBT (Quarter) stood at -$1.1 million in 2022, then crashed by 687.36% to -$8.9 million in 2023, then soared by 86.37% to -$1.2 million in 2024, then soared by 365.95% to $3.2 million in 2025.
  • Its EBT was $3.2 million in Q2 2025, compared to $103.1 million in Q1 2025 and -$1.2 million in Q3 2024.